Results: AVCT

Search articles by EPIC code
EPIC AVCT
views

The Buy or Sell Dilemma Over this Ten Bagger Continues as the Share Price Rockets to a New High

Hello Share Chompers. One of the more difficult sectors to call on this august website is in the covid-testing game. Of course, there are loads of aspirants to the title of being a good tester, but perhaps Avacta (AVCT) is the most covered. It certainly attracts a disproportionate number of posters on other websites, some of whom are in the hopeless optimist category...

EPIC AVCT
views

This Share Tom Has No Time For, Keeps on the Boil and Could be Worth another Look

Hello, Share Seekers. It’s never easy to suggest another look at a share which Uncle Tom has criticised in the recent past. But sometimes a company becomes a bit more promising, even if it’s just because the share price continues to hold up. Remember always that the trend is your friend. I fancy the following company might still be worthy of support, but only as a short term play at current prices...

EPIC AVCT
views

Avacta makes some progress on missing the Covid boat – shares slide but valuation still bonkers

Today, from AstraZeneca (AZN) and the City of lost causes, we have news on a third vaccine against Covid-19. There will soon be a fourth and a fifth and at some stage lots of folks will ignore concerns about potential long term side effects to get vaccinated against a disease which kills 0.05% of those under 70 who catch it. And a bedwetting world can breathe a sigh of relief and, even idiots like Matt Hancock, will realise that we will not need mass testing and we can get on with our lives.

EPIC AVCT
views

Avacta shares have slumped, ahead lies collapse

As you may have gathered I have been a major sceptic of Government policies on Covid and not just in the UK. For a disease where the survival rate among under 70s is 99.95% and where the average age of death is greater than life expectancy itself, it seems to me that the policy response has been excessive and has caused and is causing utterly unjustified collateral damage.  But none the less we should all welcome news that Pfizer has a vaccine which works 90% of the time.

Page 2 of 9 (85 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

|